With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1201-26-9,3-Indolylacetone,as a common compound, the synthetic route is as follows.
[0570] Asymmetric reduction applying transaminase TA-P2-A07 was performed in buffer; iso-propyl amine and organic co-solvents such as DMSO or Acetonitrile on 5 g scale. Compound (XXI) was converted to compound (3) as described herein at a degree above 95% with an enantiomeric excess (EE) above 99% after 1 day.
1201-26-9, As the paragraph descriping shows that 1201-26-9 is playing an increasingly important role.
Reference£º
Patent; GENENTECH, INC.; F. HOFFMANN-LA ROCHE AG; CHUNG, Cheol Keun; XU, Jie; IDING, Hans; CLAGG, Kyle; DALZIEL, Michael; FETTES, Alec; GOSSELIN, Francis; LIM, Ngiap-Kie; ZHANG, Haiming; CHAKRAVARTY, Paroma; NAGAPUDI, Karthik; ROBINSON, Sarah; (241 pag.)WO2019/245974; (2019); A1;,
Indole alkaloid derivatives as building blocks of natural products from?Bacillus thuringiensis?and?Bacillus velezensis?and their antibacterial and antifungal activity study
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles